ARROWHEAD PHARMACEUTICALS, INC. Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests of $1.18 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-07.
Discontinued › Shareholders' Equity › Noncontrolling Interest Items
us-gaap:MinorityInterestDecreaseFromRedemptions · last filed 2023-08-07
- ARROWHEAD PHARMACEUTICALS, INC. noncontrolling interest, decrease from redemptions or purchase of interests for the quarter ending 2023-06-30 was $1.18M.
- ARROWHEAD PHARMACEUTICALS, INC. noncontrolling interest, decrease from redemptions or purchase of interests for the quarter ending 2023-03-31 was $999.00K.
- ARROWHEAD PHARMACEUTICALS, INC. noncontrolling interest, decrease from redemptions or purchase of interests for the quarter ending 2022-12-31 was $486.00K.
| Period end | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 3 month | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 6 month | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 9 month |
|---|---|---|---|
| 2023-06-30 | $1.18M 10-Q · filed 2023-08-07 | $2.18M derived: sum of 2 quarters · filed 2023-08-07 | $2.66M derived: sum of 3 quarters · filed 2023-08-07 |
| 2023-03-31 | $999.00K 10-Q · filed 2023-08-07 | $1.49M derived: sum of 2 quarters · filed 2023-08-07 | |
| 2022-12-31 | $486.00K 10-Q · filed 2023-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |